Biogena Group Invest AG (VIE:BIO)

Biogena Group Invest AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1.86	2.59	8.18	5.8	9.21	12.02
Cash & Short-Term Investments	1.86	2.59	8.18	5.8	9.21	12.02
Cash Growth	-73.58%	-68.33%	40.90%	-36.98%	-23.40%	600.65%
Accounts Receivable	1.92	1.4	1.39	3.4	2.33	1.48
Other Receivables	0	0.98	1.73	1.41	2.85	1.68
Receivables	1.93	2.39	3.12	4.81	5.18	3.17
Inventory	1.06	1.01	1.56	1.03	0.93	0.1
Prepaid Expenses	-	1.15	1.41	1.24	0.08	0.05
Other Current Assets	-	-	-0	0	-	-
Total Current Assets	4.84	7.14	14.27	12.88	15.4	15.34
Property, Plant & Equipment	5.85	5.94	6.2	6.43	3.07	0.67
Long-Term Investments	-	-	-	-	-	0.04
Other Intangible Assets	1.46	0.14	0.2	0.18	0.2	0.1
Long-Term Deferred Charges	-	1.38	1.61	1.83	1.86	1.52
Other Long-Term Assets	0.01	0.01	0.01	0.02	2.97	1.84
Total Assets	12.15	14.61	22.29	21.34	23.5	19.5

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	0.58	1.53	1.15	1.99	1.98	1
Accrued Expenses	-	0.71	0.82	1.54	1.18	1.39
Current Portion of Long-Term Debt	0.6	6.96	2.45	0.74	0.34	0.06
Current Portion of Leases	-	-	-	0.02	0.01	0.08
Current Unearned Revenue	1.41	0.09	0.84	1.39	0.85	0.05
Other Current Liabilities	-	0.37	0.7	0.34	1.25	1.45
Total Current Liabilities	2.58	9.65	5.96	6.01	5.61	4.03
Long-Term Debt	21.15	14.84	20.18	15.01	12.44	4.48
Long-Term Leases	-	-	-	0.04	0.02	0.03
Long-Term Unearned Revenue	0.26	0.25	0.3	0.09	0.08	0.1
Other Long-Term Liabilities	0	-	-	-0	-	-
Total Liabilities	23.99	24.75	26.44	21.15	18.14	8.64

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	1.54	1.52	1.51	1.48	1.47	1.47
Retained Earnings	-58.68	-56.55	-49.76	-43.36	-37.47	-31.45
Comprehensive Income & Other	45.3	44.89	44.09	42.07	41.35	40.85
Shareholders' Equity	-11.84	-10.14	-4.16	0.19	5.36	10.87
Total Liabilities & Equity	12.15	14.61	22.29	21.34	23.5	19.5

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	21.75	21.8	22.63	15.8	12.81	4.64
Net Cash (Debt)	-19.89	-19.21	-14.45	-10	-3.61	7.38
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-	-12.65	-9.64	-6.77	-2.45	5.20
Filing Date Shares Outstanding	-	1.54	1.52	1.49	1.47	1.47
Total Common Shares Outstanding	-	1.52	1.51	1.48	1.47	1.47
Working Capital	2.26	-2.52	8.31	6.86	9.79	11.31
Book Value Per Share	-	-6.65	-2.76	0.13	3.64	7.39
Tangible Book Value	-13.3	-10.28	-4.35	0.01	5.16	10.76
Tangible Book Value Per Share	-	-6.74	-2.89	0.01	3.51	7.32
Land	-	5.91	5.91	5.89	2.65	0.36
Machinery	-	1.44	1.31	1.26	0.84	0.57

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 24, 2026

Data Sources Report a data error